This report is not a personal recommendation and does not take into account your personal circumstances or appetite for risk.
The below stocks have been identified as having potential to register bigger than normal share price moves (up or down) today based on the news cited
UK Index Miners could be sensitive to falls in global commodity futures prices (steel, iron ore, coal)
Rio Tinto to sell a 68.62% stake in Namibian uranium mine Rössing to China National Uranium Corporation for $106.5m ($6.5m initial cash + up to $100m contingent payment based on uranium spot prices).
AstraZeneca received US FDA orphan drug designation (allowing for tax benefits and incentives) for Fesenra treatment of rare EGPA autoimmune disease.
Faroe Petroleum received a £607.9m takeover offer from DNO ASA (152p/share implied share price, 20.8% premium to Friday’s closing price).
(Sources: Company newswires, Bloomberg, CNBC, FT, Reuters, Wall Street Journal)
For more information on any of these individual news items, call into the trading floor
Stock | Code | Close | High | Low |
FLYBE | FLYB | 76.1% | 97.9% | 11.7% |
BP | BP/ | -3.4% | -0.5% | -4.5% |
INDIVIOR | INDV | 3.2% | 5.4% | 0.7% |
IBSTOCK | IBST | 8.1% | 11.5% | 6.8% |
This research is produced by Accendo Markets Limited. Research produced and disseminated by Accendo Markets is classified as non-independent research, and is therefore a marketing communication. This investment research has not been prepared in accordance with legal requirements designed to promote its independence and it is not subject to the prohibition on dealing ahead of the dissemination of investment research. This research does not constitute a personal recommendation or offer to enter into a transaction or an investment, and is produced and distributed for information purposes only.
Accendo Markets considers opinions and information contained within the research to be valid when published, and gives no warranty as to the investments referred to in this material. The income from the investments referred to may go down as well as up, and investors may realise losses on investments. The past performance of a particular investment is not necessarily a guide to its future performance.
Prepared by Michael van Dulken, Head of Research